Neurogen Corporation is a drug discovery and development company focusing on small molecule drugs to improve the lives of patients suffering from disorders with significant unmet medical need, including insomnia, obesity, pain, Parkinson's disease, and restless legs syndrome (RLS). Neurogen conducts its research and development independently and, when advantageous, collaborates with world-class pharmaceutical companies to access additional resources and expertise.

Contact Information

35 Northeast Industrial Road
Branford, CT 06405

tel: 203-488-8201
fax: 203-481-8683


Investor Relations



Exchange: NASDAQ
Industry: Drug Manufacturers - Other
Market Cap: $32.3M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.